MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please refer to attached details w.r.t., loss of share certificate.19-08-2023
MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please refer to attached details w.r.t., loss of share certificate.MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Restructuring
Disclosure under Regulation 30 of SEBI(LODR) Regulations, 2015MOREPEN LABORATORIES LTD. - 500288 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 14, 2023
Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform that, the Board of Directors of the company in their meeting held Monday i.e., August 14, 2023 (commenced at 05:00 P.M. and concluded at 06:00 P.M.), inter-alia, considered and approved the transfer of Formulation Distribution & Marketing Business of the company on a slump sale basis as a going concern to Morepen Rx Limited (wholly owned subsidiary). The revenues and profits derived from the said subsidiary will be consolidated in the parent company, Morepen Laboratories Limited (MLL). The relevant information pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, is enclosed herewithMOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share certificates.MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investors presentation (Q1'' FY24), on the financial performance of the company for the quarter ended on 30th June 2023.MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of the financial results, for the quarter ended on 30th June 2023.MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Change in Management
Re-appointment of Mr. Sushil Suri as Chairman & Managing Director of the company with effect from 20 October 2023, for three years.MOREPEN LABORATORIES LTD. - 500288 - Results-Unaudited Financial Results For The Quarter Ended 30 June 2023
Unaudited financial results for the quarter ended 30th June 2023MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Change in Management
We wish to inform you that Mr. Dinesh Dhudabhai Moga, GM-ADL & QC, being a functional head and Senior Management Personnel of the company has resigned on 31st July 2023 due to his family'' commitments.MOREPEN LABORATORIES LTD. - 500288 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 30Th June 2023
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2023 ,inter alia, to consider and approve the unaudited financial results for the quarter ended 30th June 2023